Ranbaxy/GSK Partnership Yields First Drug Candidate
This article was originally published in PharmAsia News
Executive Summary
Ranbaxy and GlaxoSmithKline have identified the first clinical candidate to be developed under their discovery alliance, the two firms announced April 2
You may also be interested in...
Ranbaxy Files For Phase I Trial On First Compound From GSK Deal
MUMBAI - A year after identifying a potential compound targeted at respiratory inflammation for joint development with GSK Pharma, India's largest drug maker, Ranbaxy has submitted an application to the Drug Controller General of India to initiate Phase I trials
Ranbaxy Files For Phase I Trial On First Compound From GSK Deal
MUMBAI - A year after identifying a potential compound targeted at respiratory inflammation for joint development with GSK Pharma, India's largest drug maker, Ranbaxy has submitted an application to the Drug Controller General of India to initiate Phase I trials